Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Food Chem Toxicol ; 78: 105-15, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25660481

RESUMEN

This research aimed to develop in vitro methods to assess hazard of canine food ingredients. Canine hepatocytes were harvested and cell viability of clove-leaf oil (CLO), eugenol (EUG), lemongrass oil (LGO), guanosine monophosphate (GMP), inosine monophosphate (IMP), sorbose, ginger-root extract (GRE), cinnamon-bark oil (CBO), cinnamaldehyde (CINA), thymol oil (TO), thymol (THYM), and citric acid were assessed with positive controls: acetaminophen (APAP), aflatoxin B1 and xylitol. Molecular Toxicology PathwayFinder array (MTPF) analyzed toxicity mechanisms for LGO. LC50 for APAP was similar among human (3.45), rat (2.35), dog (4.26 mg/ml). Aflatoxin B1 had an LC50 of 4.43 (human), 5.78 (rat) and 6.05 (dog) µg/ml; xylitol did not decrease viability. LC50 of CLO (0.185 ± 0.075(SD)), EUG (0.165 ± 0.112), LGO (0.220 ± 0.012), GRE (1.54 ± 0.31) mg/ml; GMP (166.03 ± 41.83), GMP + IMP (208.67 ± 15.27) mM; CBO (0.08 ± 0.03), CINA (0.11 ± 0.01), TO (0.21 ± 0.03), THYM (0.05 ± 0.01), citric acid (1.58 ± 0.08) mg/ml, while sorbose was non-toxic. LGO induced upregulation of 16 and down-regulation of 24 genes, which CYP and heat shock most affected. These results suggest that in vitro assays such as this may be useful for hazard assessment of food ingredients for altered hepatic function.


Asunto(s)
Alimentación Animal/normas , Inocuidad de los Alimentos , Hepatocitos/efectos de los fármacos , Acetaminofén/toxicidad , Acroleína/análogos & derivados , Acroleína/toxicidad , Aflatoxina B1/toxicidad , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Perros , Regulación hacia Abajo , Eugenol/toxicidad , Análisis de los Alimentos , Zingiber officinale/química , Zingiber officinale/toxicidad , Hepatocitos/metabolismo , Humanos , Dosificación Letal Mediana , Aceites Volátiles/toxicidad , Extractos Vegetales/toxicidad , Aceites de Plantas/toxicidad , Raíces de Plantas/química , Raíces de Plantas/toxicidad , Ratas , Terpenos/toxicidad , Timol/toxicidad , Regulación hacia Arriba , Xilitol/toxicidad
2.
Toxicol Lett ; 197(2): 128-34, 2010 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-20493935

RESUMEN

Colloidal fullerene nanoparticles (nC60) were reported to be toxic to fish brains, human cells and microorganisms, while new observations suggest that the observed toxicity may be due to tetrahydrofuran (THF) solvent or its oxidative by-products in nC60 preparations. Here, we report a novel method for preparing nC60 nanoparticles that does not use THF solvent, but provides nC60 with an average particle size of 43.8 nm and a yield approximately 100 times higher than the THF method. The prepared nC60 showed a similar antioxidant capacity compared to a water-soluble vitamin E analog. No mortality to human epidermal keratinocytes was observed at a concentration 170 times higher than the reported LC50 values for other human cell lines. No toxicity was observed to E. coli or B. subtilis at up to 342 microg/mL nC60 for 16 h, which was hundred times higher than the reported minimum inhibitory concentrations of nC60 prepared using THF method for these two bacteria. When E. coli was exposed to 85.5 microg/mL nC60 with daily passage for 4 days, the stationary phase populations at different passages were not statistically different (p = 0.05) from the control without nC60 nanoparticles. These results reveal that the intrinsic biological property of nC60 is non-toxic, confirming the prior non-toxic reports when using nC60 prepared with non-THF methods.


Asunto(s)
Bacillus subtilis/efectos de los fármacos , Células Epidérmicas , Escherichia coli/efectos de los fármacos , Fulerenos/toxicidad , Queratinocitos/efectos de los fármacos , Nanopartículas/toxicidad , Fulerenos/química , Humanos , Pruebas de Sensibilidad Microbiana , Nanopartículas/química , Tamaño de la Partícula , Pruebas de Toxicidad
3.
Philos Trans A Math Phys Eng Sci ; 368(1917): 2033-64, 2010 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-20308114

RESUMEN

Nanoporous alumina membranes exhibit high pore densities, well-controlled and uniform pore sizes, as well as straight pores. Owing to these unusual properties, nanoporous alumina membranes are currently being considered for use in implantable sensor membranes and water purification membranes. Atomic layer deposition is a thin-film growth process that may be used to modify the pore size in a nanoporous alumina membrane while retaining a narrow pore distribution. In addition, films deposited by means of atomic layer deposition may impart improved biological functionality to nanoporous alumina membranes. In this study, zinc oxide coatings and platinum coatings were deposited on nanoporous alumina membranes by means of atomic layer deposition. PEGylated nanoporous alumina membranes were prepared by self-assembly of 1-mercaptoundec-11-yl hexa(ethylene glycol) on platinum-coated nanoporous alumina membranes. The pores of the PEGylated nanoporous alumina membranes remained free of fouling after exposure to human platelet-rich plasma; protein adsorption, fibrin networks and platelet aggregation were not observed on the coated membrane surface. Zinc oxide-coated nanoporous alumina membranes demonstrated activity against two waterborne pathogens, Escherichia coli and Staphylococcus aureus. The results of this work indicate that nanoporous alumina membranes may be modified using atomic layer deposition for use in a variety of medical and environmental health applications.


Asunto(s)
Óxido de Aluminio/química , Materiales Biocompatibles Revestidos/química , Adsorción , Antibacterianos/química , Plaquetas/metabolismo , Diseño de Equipo , Escherichia coli/metabolismo , Humanos , Ensayo de Materiales , Nanoestructuras/química , Nanotecnología/métodos , Platino (Metal)/química , Polietilenglicoles/química , Staphylococcus aureus/metabolismo , Óxido de Zinc/química
4.
Photodermatol Photoimmunol Photomed ; 24(2): 61-6, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18353084

RESUMEN

BACKGROUND/PURPOSE: Isoflavones, one main group of phytoestrogens, have antioxidative and photoprotective effects in cellular and mouse studies. The aim of this study is to obtain a more comprehensive understanding of the isoflavone-mediated photoprotection with the pig skin model, a more human-resembling model. METHODS: The pig skin was treated with five well-known isoflavone compounds (genistein, equol, daidzein, biochanin A, and formononetin) and one antioxidant combination solution of 15% vitamin C and 1% vitamin E and 0.5% ferulic acid (CEF) daily for 4 days. Skin was irradiated with solar-simulated UV irradiation, 1 to 5 minimal erythema dose (MED) at 1-MED intervals. Evaluation was carried out 24 h later by colorimeter-measured erythema and sunburn cell numbers. RESULTS: Topical application of 0.5% solutions of three individual phytoestrogens - genistein, daidzein, biochanin A - are better than similar solutions of equol or formononetin in protecting pig skin from solar-simulated ultraviolet (SSUV)-induced photodamage, as measured by sunburn cell formation and/or erythema. However, the protection was less than that provided by a topical combination antioxidant standard containing 15% L-ascorbic acid, 1%alpha-tocopherol, and 0.5% ferulic acid. CONCLUSION: Isoflavones provide effective photoprotection and are good candidate ingredients for protection against ultraviolet (UV) photodamage.


Asunto(s)
Isoflavonas/farmacología , Fitoterapia , Plantas Medicinales , Piel/efectos de los fármacos , Quemadura Solar/prevención & control , Protectores Solares/farmacología , Administración Cutánea , Animales , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/farmacología , Ácido Ascórbico/uso terapéutico , Ácidos Cumáricos/administración & dosificación , Ácidos Cumáricos/farmacología , Ácidos Cumáricos/uso terapéutico , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Equol , Genisteína/administración & dosificación , Genisteína/farmacología , Genisteína/uso terapéutico , Isoflavonas/administración & dosificación , Isoflavonas/uso terapéutico , Piel/efectos de la radiación , Quemadura Solar/patología , Luz Solar/efectos adversos , Protectores Solares/administración & dosificación , Protectores Solares/uso terapéutico , Porcinos , Vitamina E/administración & dosificación , Vitamina E/farmacología , Vitamina E/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA